Life Science Compliance Update

« Previous article | Home| Next article »

November 28, 2017

The Summit on Controlled Substances – Regulation, Litigation, and Enforcement

C5group-aci-logo

The American Conference Institute is proud to host the inaugural Summit on Controlled Substances - Regulation, Litigation, and Enforcement, on January 29-31, 2018 in Washington, DC. This event offers a one-of-a-kind opportunity to gather with stakeholders from every link in the supply chain to discuss the most pressing issues surroundings the controlled substances industry, most prominently the opioid overdose crisis. 

Federal and state authorities continue to go after opioid manufacturers, distributors, pharmacies, pharmacists, physicians, nurses— anyone and everyone who has a hand in the chain of custody for these controlled substances.

In response to this most difficult and challenging landscape, this conference provides a forum for stakeholders to discuss current challenges, benchmark strategies, and join together to best prepare for the future of this critical and fast-paced industry. Highlights of this year’s event include:

  • Reassessing your Responsibilities in Light of the Changing Scope of Suspicious Order Monitoring Requirements
  • Evolution of Abuse-Deterrent Opioid Drug Products
  • Understanding and Comparing State Prescription Drug Monitoring Programs
  • Diving into the State, County, and City Opioid-Related Investigations

Attendees will hear from the Drug Enforcement Administration (DEA), the Food and Drug Administration (FDA), State Attorney Generals, U.S. Attorneys, over a dozen manufacturers, distributors, top law firm leaders, and more.

The program faculty includes representatives from Center for Lawful Access and Abuse Deterrence, Daiichi Sankyo, Inc., Eisai, Inc., Independent Pharmacy Cooperative, Miami Luken, Purdue Pharma L.P., Stericycle Inc., Teva Pharmaceuticals, and more.

Additional information on the forum can be found at http://www.AmericanConference.com/ControlledSubstances. 

« Previous article | Home| Next article »

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Newsletter


Preview | Powered by FeedBlitz

Search


 
Sponsors
December 2017
Sun Mon Tue Wed Thu Fri Sat
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31